- $2.38bn
- $6.55bn
- $7.11bn
- 69
- 84
- 55
- 79
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 6,691 | 6,091 | 6,357 | 6,856 | 7,105 |
Cost of Revenue | |||||
Gross Profit | 1,208 | 972 | 1,091 | 1,213 | 1,496 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 6,641 | 5,473 | 5,809 | 5,812 | 6,696 |
Operating Profit | 50 | 618 | 548 | 1,044 | 409 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -261 | 353 | 332 | 805 | 67 |
Provision for Income Taxes | |||||
Net Income After Taxes | -379 | 264 | 165 | 627 | -85 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -400 | 249 | 149 | 584 | -103 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -400 | 249 | 149 | 584 | -103 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.792 | 0.998 | 1.22 | 2.13 | 1.69 |
Dividends per Share |